Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion-Reference-Cited by-同舟云学术

Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion

Published:2021-03 Issue: Volume:20 Page:659-668
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Robertson Matthew Glen^ORCID,Eidenschink Benjamin Bruce,Iguchi Eriko,Zakharkin Stanislav O.^ORCID,LaRocca Christopher J.^ORCID,Tolosa Ezequiel J.^ORCID,Truty Mark J.,Jacobsen Kari,Fernandez-Zapico Martin E.,Davydova Julia^ORCID

Funder

NIH

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference35 articles.

1. The use of the NIS reporter gene for optimizing oncolytic virotherapy;Miller;Expert Opin. Biol. Ther.,2016

2. Radiovirotherapy: principles and prospects in oncology;Touchefeu;Curr. Pharm. Des.,2012

3. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer;Dwyer;Mol. Ther.,2005

4. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter;Dingli;Blood,2004

5. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus;Haddad;J. Transl. Med.,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

2. Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells;Viruses;2024-04-05

3. Viral Shedding in Mice following Intravenous Adenovirus Injection: Impact on Biosafety Classification;Viruses;2023-07-01

4. A Renaissance for Oncolytic Adenoviruses?;Viruses;2023-01-26

5. Development of Oncolytic Vectors Based on Human Adenovirus Type 6 for Cancer Treatment;Viruses;2023-01-07